Total venture capital dollars invested in medical device companies jumped more than 20% during the 2nd quarter, but early-stage companies are still out in the cold.
Life science venture capital funding saw a major boost in the 2nd quarter as public markets smiled on biotech companies, but medical device makers saw a significant boost of their own – as long as they weren't early-stage firms.
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1nCoDMu
Cap comentari:
Publica un comentari a l'entrada